Kazia Therapeutics Ltd
KZIA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001075880
No open-market purchases or sales by Kazia Therapeutics Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $50.7M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Kazia Therapeutics Ltd changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 11 | 18 | +7 |
| Shares | 391.5K | 2.15M | +1.75M (+448.0%) |
| Value | $89.5K | $922.0K | +$832.5K (+930.0%) |
New holders (10)
Institutions that held Kazia Therapeutics Ltd at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MAI Capital Management | 1,363,894 | $586.3K | 0.01% |
| Jane Street Group, LLC | 46,110 | $19.8K | 0.00% |
| United Bank | 44,000 | $18.9K | 0.00% |
| Commonwealth Equity Services, LLC | 30,500 | $13.0K | 0.00% |
| XTX Topco Ltd | 23,395 | $10.1K | 0.00% |
| Captrust Financial Advisors | 15,265 | $6.56K | 0.00% |
| Geode Capital Management, LLC | 14,784 | $6.36K | 0.00% |
| Traynor Capital Management, Inc. | 10,000 | $4.30K | 0.00% |
| Advisor Group Holdings, Inc. | 500 | $215 | 0.00% |
| Simplex Trading, LLC | 505 | $0 | 0.00% |
Sold out (3)
Institutions that held Kazia Therapeutics Ltd at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BNP Paribas Arbitrage, SA | 63,568 | $14.5K |
| Susquehanna International Group, LLP | 41,478 | $9.46K |
| Virtu Financial LLC | 39,277 | $9.00K |